Although continuous administration of IL-10-expressing probiotics has been successful in treating preclinical models of colitis (Steidler et al., 2000), this therapy has not successfully translated to humans, perhaps due the inability of chassis to survive in the luminal environment (Braat et al., 2006). The gene discussed is IL10; the disease is colitis.